These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

447 related articles for article (PubMed ID: 26290414)

  • 41. Enhanced inflammation in New Zealand white rabbits when MERS-CoV reinfection occurs in the absence of neutralizing antibody.
    Houser KV; Broadbent AJ; Gretebeck L; Vogel L; Lamirande EW; Sutton T; Bock KW; Minai M; Orandle M; Moore IN; Subbarao K
    PLoS Pathog; 2017 Aug; 13(8):e1006565. PubMed ID: 28817732
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Generation of a transgenic mouse model of Middle East respiratory syndrome coronavirus infection and disease.
    Agrawal AS; Garron T; Tao X; Peng BH; Wakamiya M; Chan TS; Couch RB; Tseng CT
    J Virol; 2015 Apr; 89(7):3659-70. PubMed ID: 25589660
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Sensitive and Specific Detection of Low-Level Antibody Responses in Mild Middle East Respiratory Syndrome Coronavirus Infections.
    Okba NMA; Raj VS; Widjaja I; GeurtsvanKessel CH; de Bruin E; Chandler FD; Park WB; Kim NJ; Farag EABA; Al-Hajri M; Bosch BJ; Oh MD; Koopmans MPG; Reusken CBEM; Haagmans BL
    Emerg Infect Dis; 2019 Oct; 25(10):1868-1877. PubMed ID: 31423970
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Inactivated Rabies Virus Vectored MERS-Coronavirus Vaccine Induces Protective Immunity in Mice, Camels, and Alpacas.
    Chi H; Wang Y; Li E; Wang X; Wang H; Jin H; Han Q; Wang Z; Wang X; Zhu A; Sun J; Zhuang Z; Zhang L; Ye J; Wang H; Feng N; Hu M; Gao Y; Zhao J; Zhao Y; Yang S; Xia X
    Front Immunol; 2022; 13():823949. PubMed ID: 35173733
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Replication and shedding of MERS-CoV in upper respiratory tract of inoculated dromedary camels.
    Adney DR; van Doremalen N; Brown VR; Bushmaker T; Scott D; de Wit E; Bowen RA; Munster VJ
    Emerg Infect Dis; 2014 Dec; 20(12):1999-2005. PubMed ID: 25418529
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Immunogenicity and structures of a rationally designed prefusion MERS-CoV spike antigen.
    Pallesen J; Wang N; Corbett KS; Wrapp D; Kirchdoerfer RN; Turner HL; Cottrell CA; Becker MM; Wang L; Shi W; Kong WP; Andres EL; Kettenbach AN; Denison MR; Chappell JD; Graham BS; Ward AB; McLellan JS
    Proc Natl Acad Sci U S A; 2017 Aug; 114(35):E7348-E7357. PubMed ID: 28807998
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Potent neutralization of MERS-CoV by human neutralizing monoclonal antibodies to the viral spike glycoprotein.
    Jiang L; Wang N; Zuo T; Shi X; Poon KM; Wu Y; Gao F; Li D; Wang R; Guo J; Fu L; Yuen KY; Zheng BJ; Wang X; Zhang L
    Sci Transl Med; 2014 Apr; 6(234):234ra59. PubMed ID: 24778414
    [TBL] [Abstract][Full Text] [Related]  

  • 48. A Comparative Review of Animal Models of Middle East Respiratory Syndrome Coronavirus Infection.
    Baseler L; de Wit E; Feldmann H
    Vet Pathol; 2016 May; 53(3):521-31. PubMed ID: 26869154
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Human neutralizing antibodies against MERS coronavirus: implications for future immunotherapy.
    Tang XC; Marasco WA
    Immunotherapy; 2015; 7(6):591-4. PubMed ID: 26098703
    [No Abstract]   [Full Text] [Related]  

  • 50. Immunization with inactivated Middle East Respiratory Syndrome coronavirus vaccine leads to lung immunopathology on challenge with live virus.
    Agrawal AS; Tao X; Algaissi A; Garron T; Narayanan K; Peng BH; Couch RB; Tseng CT
    Hum Vaccin Immunother; 2016 Sep; 12(9):2351-6. PubMed ID: 27269431
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Cross-sectional surveillance of Middle East respiratory syndrome coronavirus (MERS-CoV) in dromedary camels and other mammals in Egypt, August 2015 to January 2016.
    Ali M; El-Shesheny R; Kandeil A; Shehata M; Elsokary B; Gomaa M; Hassan N; El Sayed A; El-Taweel A; Sobhy H; Fasina FO; Dauphin G; El Masry I; Wolde AW; Daszak P; Miller M; VonDobschuetz S; Morzaria S; Lubroth J; Makonnen YJ
    Euro Surveill; 2017 Mar; 22(11):. PubMed ID: 28333616
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Severe acute respiratory syndrome vs. the Middle East respiratory syndrome.
    Hui DS; Memish ZA; Zumla A
    Curr Opin Pulm Med; 2014 May; 20(3):233-41. PubMed ID: 24626235
    [TBL] [Abstract][Full Text] [Related]  

  • 53. A humanized neutralizing antibody against MERS-CoV targeting the receptor-binding domain of the spike protein.
    Li Y; Wan Y; Liu P; Zhao J; Lu G; Qi J; Wang Q; Lu X; Wu Y; Liu W; Zhang B; Yuen KY; Perlman S; Gao GF; Yan J
    Cell Res; 2015 Nov; 25(11):1237-49. PubMed ID: 26391698
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Development of Middle East Respiratory Syndrome Coronavirus vaccines - advances and challenges.
    Cho H; Excler JL; Kim JH; Yoon IK
    Hum Vaccin Immunother; 2018 Feb; 14(2):304-313. PubMed ID: 29048984
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Advances in the Animal Models of MERS-CoV].
    Lan J; Deng Y; Tan W
    Bing Du Xue Bao; 2016 May; 32(3):369-75. PubMed ID: 29963837
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Human polyclonal immunoglobulin G from transchromosomic bovines inhibits MERS-CoV in vivo.
    Luke T; Wu H; Zhao J; Channappanavar R; Coleman CM; Jiao JA; Matsushita H; Liu Y; Postnikova EN; Ork BL; Glenn G; Flyer D; Defang G; Raviprakash K; Kochel T; Wang J; Nie W; Smith G; Hensley LE; Olinger GG; Kuhn JH; Holbrook MR; Johnson RF; Perlman S; Sullivan E; Frieman MB
    Sci Transl Med; 2016 Feb; 8(326):326ra21. PubMed ID: 26888429
    [TBL] [Abstract][Full Text] [Related]  

  • 57. An Acute Immune Response to Middle East Respiratory Syndrome Coronavirus Replication Contributes to Viral Pathogenicity.
    Baseler LJ; Falzarano D; Scott DP; Rosenke R; Thomas T; Munster VJ; Feldmann H; de Wit E
    Am J Pathol; 2016 Mar; 186(3):630-8. PubMed ID: 26724387
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Vaccines for the prevention against the threat of MERS-CoV.
    Du L; Tai W; Zhou Y; Jiang S
    Expert Rev Vaccines; 2016 Sep; 15(9):1123-34. PubMed ID: 26985862
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Middle East Respiratory Syndrome: Emergence of a Pathogenic Human Coronavirus.
    Fehr AR; Channappanavar R; Perlman S
    Annu Rev Med; 2017 Jan; 68():387-399. PubMed ID: 27576010
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Etiological, epidemiological and clinical aspects of coronavirus infection MERS-CoV].
    Gańczak M
    Pol Merkur Lekarski; 2015 Jan; 38(223):46-50. PubMed ID: 25763589
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.